Multicenter Studies as Topic
"Multicenter Studies as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about controlled studies which are planned and carried out by several cooperating institutions to assess certain variables and outcomes in specific patient populations, for example, a multicenter study of congenital anomalies in children.
Descriptor ID |
D015337
|
MeSH Number(s) |
E05.318.760.658 N05.715.360.775.508 N06.850.520.450.643
|
Concept/Terms |
Multicenter Trials- Multicenter Trials
- Multicenter Trial
- Trial, Multicenter
- Trials, Multicenter
- Multicentre Trials
- Multicentre Trial
- Trial, Multicentre
- Trials, Multicentre
|
Below are MeSH descriptors whose meaning is more general than "Multicenter Studies as Topic".
Below are MeSH descriptors whose meaning is more specific than "Multicenter Studies as Topic".
This graph shows the total number of publications written about "Multicenter Studies as Topic" by people in this website by year, and whether "Multicenter Studies as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 2 | 2 |
1995 | 0 | 2 | 2 |
1997 | 0 | 2 | 2 |
1999 | 0 | 2 | 2 |
2000 | 0 | 5 | 5 |
2001 | 0 | 2 | 2 |
2002 | 0 | 4 | 4 |
2003 | 0 | 2 | 2 |
2004 | 0 | 3 | 3 |
2005 | 0 | 6 | 6 |
2006 | 1 | 14 | 15 |
2007 | 1 | 4 | 5 |
2008 | 1 | 5 | 6 |
2009 | 0 | 6 | 6 |
2010 | 0 | 5 | 5 |
2011 | 0 | 5 | 5 |
2012 | 3 | 7 | 10 |
2013 | 4 | 3 | 7 |
2014 | 0 | 2 | 2 |
2015 | 0 | 1 | 1 |
2016 | 2 | 3 | 5 |
2017 | 0 | 1 | 1 |
2018 | 1 | 3 | 4 |
2019 | 0 | 3 | 3 |
2020 | 1 | 3 | 4 |
2021 | 0 | 3 | 3 |
2022 | 0 | 6 | 6 |
2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Multicenter Studies as Topic" by people in Profiles.
-
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. PLoS One. 2023; 18(6):e0286297.
-
Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial). BMJ Open. 2023 04 06; 13(4):e068363.
-
Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study. Inflamm Bowel Dis. 2023 03 01; 29(3):417-422.
-
Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial. Future Oncol. 2022 Dec; 18(38):4161-4170.
-
Safety and Success Rates of Excimer Laser Sheath-Assisted Retrieval of Embedded Inferior Vena Cava Filters. JAMA Netw Open. 2022 12 01; 5(12):e2248159.
-
RISE FOR HEALTH: Rationale and protocol for a prospective cohort study of bladder health in women. Neurourol Urodyn. 2023 06; 42(5):998-1010.
-
Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsies. Prostate Cancer Prostatic Dis. 2022 09; 25(3):422-430.
-
The Opioid Analgesic Reduction Study (OARS)-a comparison of opioid vs. non-opioid combination analgesics for management of post-surgical pain: a double-blind randomized clinical trial. Trials. 2022 Feb 17; 23(1):160.
-
Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance). J Clin Oncol. 2022 03 01; 40(7):740-751.
-
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series. Eur J Intern Med. 2021 11; 93:87-94.